EBA
HAE icon

Eagle Bay Advisors’s Haemonetics HAE Stock Holding History

Eagle Bay Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-54
Closed -$4.22K – 477
2024
Q4 		$4.22K Buy
54
+19
+54% +$1.53K ﹤0.01% 736
2024
Q3 		$2.81K Sell
35
-19
-35% -$1.53K ﹤0.01% 1153
2024
Q2 		$4.47K Sell
54
-17
-24% -$1.5K ﹤0.01% 738
2024
Q1 		$6.06K Sell
71
-26
-27% -$2.04K ﹤0.01% 679
2023
Q4 		$8.29K Sell
97
-673
-87% -$58.2K 0.01% 559
2023
Q3 		$69K Buy
770
+151
+24% +$13.5K 0.03% 340
2023
Q2 		$52.7K Sell
619
-59
-9% -$4.99K 0.03% 354
2023
Q1 		$56.1K Sell
678
-114
-14% -$9.23K 0.03% 358
2022
Q4 		$62.3K Buy
792
+151
+24% +$12.1K 0.03% 331
2022
Q3 		$48K Sell
641
-12
-2% -$862 0.03% 346
2022
Q2 		$42.6K Buy
653
+397
+155% +$23.5K 0.03% 401
2022
Q1 		$16K Sell
256
-66
-20% -$3.59K 0.01% 242
2021
Q4 		$18K Buy
322
+74
+30% +$4.51K 0.01% 583
2021
Q3 		$17K Buy
248
+2
+0.8% +$126 0.01% 645
2021
Q2 		$18K Buy
+246
New +$17.4K 0.01% 563

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Eagle Bay Advisors's HAE Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Haemonetics (HAE) in Q1 2025, closing a stake of 54 shares — an estimated $4.22K sold.

Eagle Bay Advisors first reported a position in HAE in Q2 2021 and held it in 15 quarters. The position peaked at $69K in Q3 2023. 314 funds tracked by Wall St. Rank hold HAE as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Haemonetics position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 54 Haemonetics shares in Q1 2025, an estimated $4.22K.
  • Eagle Bay Advisors first reported a position in Haemonetics in Q2 2021 and held it in 15 quarters.
  • Eagle Bay Advisors's Haemonetics position peaked at $69K in Q3 2023.
  • 314 funds tracked by Wall St. Rank held Haemonetics as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.